A Pivotal Day for Geron
Geron Corporation shared a post on LinkedIn:
“A pivotal day for Geron.
Today, we shared our Q2 results – highlighting strong commercial momentum and continued progress across our development pipeline.
We also announced the appointment of Harout Semerjian as our next President and CEO, effective August 7. A seasoned commercial leader in hematology and oncology, Harout brings clarity, conviction, and a deep commitment to patients as we enter our next phase of growth.
Progress. Science. Leadership.
Get a closer look at what’s ahead – including perspectives from Harout and our executive team.
Stay tuned tomorrow as we officially welcome Harout to Team Geron.”
Harout Semerjian, President and CEO at Geron Corporation, shared Geron Corporation’s post on LinkedIn:
“Joining Geron Corporation at this pivotal moment, with a mission that resonates deeply for me is both a privilege and responsibility. What brought me here is simple: The opportunity to make a difference for patients, alongside a team that’s fully committed to the same purpose. I look forward to listening, learning and leading as part of Team Geron. Let’s build our future together.”
Watch this engaging interview featuring Harout Semerjian on biotech innovation, legacy, and leadership in conversation with Roupen Odabashian on OncoDaily.
More posts featuring Harout Semerjian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023